Atom Investors LP Oric Pharmaceuticals, Inc. Transaction History

Atom Investors LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.63 - $12.93 $36,504 - $71,192	5,506 Added 17.54%	36,901 $260,000
Q1 2024 May 15, 2024	SELL	$8.04 - $16.03 $73,582 - $146,706	-9,152 Reduced 22.57%	31,395 $431,000
Q4 2023 Feb 14, 2024	BUY	$5.41 - $9.43 $34,115 - $59,465	6,306 Added 18.42%	40,547 $373,000
Q3 2023 Nov 14, 2023	SELL	$6.05 - $9.28 $70,524 - $108,176	-11,657 Reduced 25.4%	34,241 $207,000
Q2 2023 Aug 14, 2023	SELL	$4.95 - $8.4 $98,410 - $167,000	-19,881 Reduced 30.22%	45,898 $356,000
Q1 2023 May 15, 2023	SELL	$4.26 - $6.75 $247,258 - $391,783	-58,042 Reduced 46.88%	65,779 $374,000
Q4 2022 Feb 14, 2023	SELL	$2.41 - $5.89 $16,195 - $39,580	-6,720 Reduced 5.15%	123,821 $729,000
Q3 2022 Nov 08, 2022	BUY	$3.15 - $5.24 $163,229 - $271,531	51,819 Added 65.83%	130,541 $418,000
Q2 2022 Aug 15, 2022	BUY	$2.7 - $7.07 $212,549 - $556,564	78,722 New	78,722 $353,000

124

66.6M

7.8K

700

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $336M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.